Marta Szostek

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

Marek Hus, Norbert Grząśko, Marta Szostek et al. · Annals of Hematology · 2011 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Blood and synovial fluid calprotectin as biomarkers to diagnose chronic hip and knee periprosthetic joint infections

Dariusz Grzelecki, Piotr Walczak, Marta Szostek et al. · The Bone & Joint Journal · 2020 · 52 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

The effect of β-carotene and its derivatives on cytotoxicity, differentiation, proliferative potential and apoptosis on the three human acute leukemia cell lines: U-937, HL-60 and TF-1

Tomasz Sacha, Magdalena Zawada, J. Hartwich et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2005 · 26 citations · Full text

Life Sciences, Biochemistry, Oncology +9

90Y-Zevalin® (90Y-Ibritumomab Tiuxetan) Radioimmunotherapy (RIT) Consolidation of FCM Induction Chemotherapy in Mantle Cell Lymphoma (MCL) Patients: Results from the PLRG upon Completed Enrollment.

Wojciech Jurczak, Agnieszka Giza, Marta Szostek et al. · Blood · 2006 · 17 citations

Medicine, Oncology, Pharmacotherapy +11

Elevated plasma D‐dimer concentration has higher efficacy for the diagnosis of periprosthetic joint infection of the knee than of the hip—A single‐center, retrospective study

Dariusz Grzelecki, Piotr Walczak, Aleksandra Grajek et al. · Journal of Orthopaedic Research® · 2020 · 15 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17